SPEAKER PROFILES:

Prof Shahin Sayed
Shahin Sayed is Associate Professor and Consultant in Anatomical Pathology and Cytology, in the Department of Pathology, Medical College, Aga Khan University and the current Chair and Laboratory Director of Pathology at AKUH, Nairobi.

Dr Sayed graduated from the University of Nairobi with a Bachelor of Medicine and Surgery degree. She holds a Master of Medicine in General Pathology from the University of Nairobi where she was awarded the best student in Pathology prize. She is a Fellow of the Royal College of Pathologists, United Kingdom and a Fellow of the College of Pathologists of East Central and Southern Africa.

Dr. Sayed is the Secretary General of the College of Pathologists of East Central and Southern Africa, Chair of the Academic Committee of the Senate – East Central and Southern African (ECSA) College of Health Sciences, Chair of theBoard of Directors of African Strategies for Advancing Pathology (ASAP, co-chair Technical Working Group (TWG) on Diagnostics for the Cancer Control Programme – Ministry of Health, Kenya (MoH).

She is also a steering committee member and Commissioner for the Lancet Commission on Diagnostics and a member of the Lancet Oncology Commission for Sub-Saharan Africa. She has also been a recent member of the WHO-SAGE IVD Committee (2019-2020). Dr. Sayed is a member of the United States and Canadian Academy of Pathology (USCAP) and the American Society of Clinical Oncology (ASCO).

Dr. Sayed is in charge of the breast service at AKUHN. Her research interest span oncopathology with a special focus in breast cancer and solid haematolymphoid malignancies. She has several grants and peer reviewed publications in her area of research interest. She has also led research initiatives and interventions that have developed a sustainable model of community-based engagement to improve breast cancer screening and diagnosis.

Prof Mansoor Saleh
Mansoor Saleh, MD received his early education in the Aga Khan School system in East Africa, his medical education at the University of Heidelberg in Germany and conducted his doctoral research at the Max Planck Institute for Medical Research in Heidelberg.

He received his training in internal medicine at the Henry Ford Hospital in Detroit Michigan and clinical and translational research training in Hematology & Oncology at the University of Alabama Comprehensive Cancer Center in Birmingham, Alabama where he was tenured Professor of Medicine & Pathology and Director of the First-in-Human Early Drug Development Program. His area of research and clinical focus is “targeted therapy of cancer”. In January 2020, he joined the Aga Khan University in Nairobi, Kenya as the Founding Chair, Department of Hematology – Oncology and Founding Director – AKU, N Cancer Center.

Dr Allan Njau
Allan Njau is a Senior Clinical Instructor in the department of Pathology and Laboratory Medicine at the Aga Khan University Hospital, Nairobi, Kenya.

He holds a bachelor’s degree in Medicine and Surgery from the University of Nairobi (2008), Master of medicine in Anatomic Pathology from the Aga Khan University (2016) and a fellowship in Molecular Pathology from Augusta University, GA, USA (2020).

His roles include clinical service in the Anatomic Pathology and Molecular Pathology sections of the institution as well as teaching. His interests are in the fields of molecular assays especially for oncology testing, bioinformatics and artificial intelligence applications in molecular pathology, laboratory management and hepatobiliary pathology. His past and current research engagements are in the areas of pathology informatics, Acute myeloid leukemia, endometrial carcinoma, extrapulmonary tuberculosis, COVID-19, gastric cancer, and Helicobacter pylori infections. He is a member of the Association for Molecular Pathology and American Association of Cancer Research.

Moderator: Dr Andrew Odhiambo
Andrew Odhiambo is a Consultant Physician/Medical Oncologist & Program Director/Lecturer (Medical Oncology Fellowship Program) at the University of Nairobi. Dr. Andrew holds a Master’s degree in Internal Medicine from the University of Nairobi. He has attended preceptorship training in Haematological Oncology & Infectious Diseases from the University of Maryland Marleen & Stewart Greenbaum Cancer Centre in the United States. He later did his Fellowship in Medical Oncology in the United Kingdom and was certified by the Federation of Royal College of Physicians of the United Kingdom as well as the Association of Cancer Physicians and the European Society for Medical Oncology. He is also a Fellow of the Royal College of Physicians of Edinburgh as well as the East, Central & Southern Africa College of Physicians.

He is the outgoing Secretary & former Treasurer of Kenya Society of Haematology & Oncology (KESHO). Dr. Andrew is a member of KAP, ASCO, ESMO, AORTIC & ECSACOP. Dr. Andrew serves as an expert advisor for local and international bodies i.e. MOH, Kenya Cancer Prevention TWG, ASCO & NCCN Cancer Treatment Guidelines Committees. He has published several articles on cancer in both international and local peer reviewed scientific journals.

Dr. Andrew was awarded the prestigious Business Daily Africa Top 40 under 40 men in the year 2017. He is passionate about cancer education and awareness especially through digital platforms. He has over 50 appearances in mainstream local and international TV and print media promoting cancer awareness.
His key areas of sub specialization and interest include Colon cancer, Stomach cancer, Breast Cancer, Pancreatic, Liver & Bile Duct cancer, Cancer or Unknown Primary, Lymphoma as well as newer treatments i.e. Immunotherapy & Targeted therapy for Colon, Skin, Lung, Kidney cancers etc. For his full profile, please visit www.drandrewodhiambo.com